Analyst firms · Chardan Capital Markets · CRVO
Chardan Capital Markets CRVO price target and rating history
CervoMed Inc. (CRVO) · Health Care
Chardan Capital Markets rates CervoMed Inc. (CRVO) Buy with a $14 price target, as of its latest action on Mar 13, 2025. It has published 3 rating actions on CRVO since September 2024, including 1 upgrade and 1 downgrade.
- Current rating
- Buy
- Price target
- $14
- Median target, all firms
- Too few
- Actions on CRVO
- 3
Chardan Capital Markets price target on CRVO
Every Chardan Capital Markets rating on CRVO
- Mar 13, 2025
- Dec 11, 2024
- Sep 18, 2024
Questions about Chardan Capital Markets and CRVO
- What is Chardan Capital Markets's price target for CRVO?
- Chardan Capital Markets's latest stated price target for CervoMed Inc. (CRVO) is $14, from its action on Mar 13, 2025.
- What is Chardan Capital Markets's rating on CRVO?
- Chardan Capital Markets rates CRVO Buy, a bullish rating, as of Mar 13, 2025.
- When did Chardan Capital Markets last change its view on CRVO?
- On Mar 13, 2025, Chardan Capital Markets upgrades to Buy from Neutral, price target $14.
All Chardan Capital Markets ratingsCRVO news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.